Biomarkers: Validation and Verification

The biomarker validation study represents a key step for the translation of the bench findings into clinical practice for tailored prescription or to accelerate the development of new drugs and other medical products. Biomarker validation is a multifaceted procedure that requires collaboration of multiple clinical centers and carries a significant financial burden and for which robust quantitative assays have been developed will enter the validation phase.

  • Biomarker validation
  • Biomarker identification

Related Conference of Biomarkers: Validation and Verification

May 16-17, 2024

44th Euro Congress on Cancer Science & Therapy

Rome, Italy
June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
June 13-14, 2024

21st International Conference on Breast Pathology and Cancer Diagnosis

Rome, Italy
June 13-14, 2024

14th World Congress on Breast Cancer Research & Therapies

Rome, Italy
June 17-18, 2024

2nd International Conference on Cancer Biology and Therapeutics

Rome, Italy
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

22nd International Conference on Cancer Biology and Cell Science

Paris, France
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
September 19-20, 2024

15th International Conference on Cancer Stem Cell & Oncology Research

Paris, France
September 19-20, 2024

37th Conference on Preventive Oncology and Diagnostic Cancer

Paris, France
October 24-25, 2024

3rd Experts Meeting on Cancer Medicine, Radiology & Treatment

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Biomarkers: Validation and Verification Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in